Cargando…
RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations
Activating mutations in the Wnt pathway are a characteristic feature of colorectal cancer (CRC). The R-spondin (RSPO) family is a group of secreted proteins that enhance Wnt signaling and RSPO2 and RSPO3 gene fusions have been reported in CRC. We have previously shown that Wnt pathway blockers exhib...
Autores principales: | Fischer, Marcus M., Yeung, V. Pete, Cattaruzza, Fiore, Hussein, Rajaa, Yen, Wan-Ching, Murriel, Christopher, Evans, James W., O’Young, Gilbert, Brunner, Alayne L., Wang, Min, Cain, Jennifer, Cancilla, Belinda, Kapoun, Ann, Hoey, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681666/ https://www.ncbi.nlm.nih.gov/pubmed/29127379 http://dx.doi.org/10.1038/s41598-017-15704-y |
Ejemplares similares
-
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
por: Fischer, Marcus M., et al.
Publicado: (2017) -
Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses
por: Srivastava, Minu, et al.
Publicado: (2015) -
Intratumoral heterogeneity generated by Notch signaling promotes small cell lung cancer
por: Lim, Jing Shan, et al.
Publicado: (2017) -
Rspo2 inhibits TCF3 phosphorylation to antagonize Wnt signaling during vertebrate anteroposterior axis specification
por: Reis, Alice H., et al.
Publicado: (2021) -
Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells
por: Kriz, Vitezslav, et al.
Publicado: (2018)